Exhaled nitric oxide in childhood allergic asthma management: A randomised controlled trial

Pediatric Pulmonology

Volumn 49, Issue 7, 2014, Pages 624-631

  Peirsman, Eva J ^a   Carvelli, Thierry J ^b   Hage, Pierre Y ^c   Hanssens, Laurence S ^c   Pattyn, Luc ^d   Raes, Marc M ^e   Sauer, Kate A ^f   Vermeulen, Françoise ^g   Desager, Kristine N ^a,h  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Centre Hospitalier Peltzer La Tourelle   (Belgium)

^c HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^d Algemeen Ziekenhuis Sint Jozef   (Belgium)

^e Jessa Ziekenhuis   (Belgium)

^f General Hospital St Jan   (Belgium)

^g ERASME HOSPITAL   (Belgium)

^h ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

airway inflammation; asthma exacerbations; inhaled corticosteroids; leukotriene receptor antagonist

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NITRIC OXIDE; ANTIASTHMATIC AGENT; BIOLOGICAL MARKER;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE BLIND PROCEDURE; ALGORITHM; ASTHMA; BREATH ANALYSIS; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; DRUG ADMINISTRATION; FEMALE; MALE; METABOLISM; STATISTICAL MODEL; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ALGORITHMS; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT TECHNIQUES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; LOGISTIC MODELS; MALE; NITRIC OXIDE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84903398568     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22873     Document Type: Article

References (27)

1. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2006. Available from: http://www.ginasthma.org/
2. Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G, Hodgdon K, Morgan W, Sorkness CA, Lemanske RF Jr., Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003; 112: 883-892.
3. Tillie-Leblond I, Montani D, Crestani B, de Blic J, Humbert M, Tunon-de-Lara M, Magnan A, Roche N, Ostinelli J, Chanez P,. Relation between inflammation and symptoms in asthma. Allergy 2009; 64: 354-367.
4. Sont JK, Han J, van Krieken JM, Evertse CE, Hooijer R, Willems LN, Sterk PJ,. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996; 51: 496-502.
5. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB,. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001; 164: 2107-2113.
6. Prescott SL,. The development of respiratory inflammation in children. Paediatr Respir Rev 2006; 7: 89-96.
7. Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC,. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005; 60: 215-218.
8. Petsky HL, Cates CJ, Lasserson TJ, Li AM, Turner C, Kynaston JA, Chang AB,. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012; 67: 199-208.
9. Nelson BV, Sears S, Woods J, Ling CY, Hunt J, Clapper LM, Gaston B,. Expired nitric oxide as a marker for childhood asthma. J Pediatr 1997; 130: 423-427.
10. Alving K, Malinovschi A,. Basic aspects of exhaled nitric oxide. In:, Horvath I, de Jongste JC,. editors. Exhaled Biomarkers, European Respiratory Monograph. Lausanne: European Respiratory Society; 2010. pp 1-31.
11. Piacentini GL, Bodini A, Costella S, Vicentini L, Mazzi P, Sperandio S, Boner AL,. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J 1999; 13: 1386-1390.
12. Verini M, Peroni DG, Piacentini GL, Nicodemo A, Rossi N, Bodini A, Chiarelli F, Boner AL,. Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures. Allergy Asthma Proc 2007; 28: 691-694.
13. Harkins MS, Fiato KL, Iwamoto GK,. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004; 41: 471-476.
14. Khalili B, Boggs PB, Bahna SL,. Reliability of a new hand-held device for the measurement of exhaled nitric oxide. Allergy 2007; 62: 1171-1174.
15. Buchvald F, Baraldi E, Carraro S, Gaston B, De Jongste J, Pijnenburg MW, Silkoff PE, Bisgaard H,. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005; 115: 1130-1136.
16. Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ,. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003; 21: 433-438.
17. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
18. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R,. Development and cross-sectional validation of the childhood asthma control test. J Allergy Clin Immunol 2007; 119: 817-825.
19. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC,. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005; 172: 831-836.
20. Gibson PG,. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies. Clin Exp Allergy 2009; 39: 478-490.
21. Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, Zamel N,. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010; 138: 682-692.
22. Fritsch M, Uxa S, Horak FJr, Putschoegl B, Dehlink E, Szepfalusi Z, Frischer T,. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006; 41: 855-862.
23. de Jongste JC, Carraro S, Hop WC, Study CHARISM Group, Baraldi E,. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009; 179: 93-97.
24. Verini M, Consilvio NP, Di Pillo S, Cingolani A, Spagnuolo C, Rapino D, Scaparrotta A, Chiarelli F,. FeNO as a marker of airways inflammation: the possible implications in childhood asthma management. J Allergy (Cairo) 2010; 2010: 1-7.
25. Pike K, Selby A, Price S, Warner J, Connett G, Legg J, Lucas JS, Peters S, Buckley H, Magier K, Foote K, Drew K, Morris R, Lancaster N, Roberts G,. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial. Clin Respir J 2012 [Epub ahead of print].
26. Diamant Z, Mantzouranis E, Bjermer L,. Montelukast in the treatment of asthma and beyond. Expert Rev Clin Immunol 2009; 5: 639-658.
27. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu AH, Wildfire JJ, Curry MD, Busse WW,. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008; 372: 1065-1072.